4
Changes in Ownership
ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000033
CEO bought 374,200 shares at an average $0.01 ($3,797)
From the SEC's structured data for this filing
Trades in this filing
Collier Alan Brian · CEO
Table I: Non-derivative
26 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-05-22 | Purchase : show line 1 in the form | +5,000 | $0.01 | $54 | 22,925,397 | D |
| 2019-05-22 | Purchase : show line 2 in the form | +2,000 | $0.01 | $22 | 22,927,397 | D |
| 2019-05-22 | Purchase : show line 3 in the form | +25,000 | $0.01 | $260 | 22,952,397 | D |
| 2019-05-22 | Purchase : show line 4 in the form | +10,000 | $0.01 | $104 | 22,962,397 | D |
| 2019-05-22 | Purchase : show line 5 in the form | +2,000 | $0.01 | $23 | 22,964,397 | D |
| 2019-05-22 | Purchase : show line 6 in the form | +5,000 | $0.01 | $56 | 22,969,397 | D |
| 2019-05-22 | Purchase : show line 7 in the form | +20,000 | $0.01 | $224 | 22,989,397 | D |
| 2019-05-22 | Purchase : show line 8 in the form | +5,000 | $0.01 | $53 | 22,994,397 | D |
| Open-market purchases · 374,200 sh · avg $0.01 · $3,797 | ||||||
Loading xslF345X03/primary_doc.xml…